Your Article Summary
See Latest ArticlesNewer therapies for vasculitis
Best Practice & Research: Clinical Rheumatology, 07/01/09
Hiemstra TF et al. - B-cell depletion with rituximab is currently attracting most attention with good success rates in small studies of refractory disease. The treatment of vasculitis in the future will become more complex with a wider range of available treatments; their optimal combination, sequencing and tailoring to the individual clinical situation will place unique demands on those delivering vasculitis services.
Related Articles
European League Against Rheumatism/European Vasculitis Study Group recommendations for the management of vasculitis
Current Opinion in Rheumatology, 10/16/09
Relevance Score: 92%
Resolution of anti-neutrophil cytoplasmic antibody-associated vasculitis after resection of gastric cancer
Modern Rheumatology, 10/19/09
Relevance Score: 91%
Progress Towards a Core Set of Outcome Measures in Small-vessel Vasculitis. Report from OMERACT 9
Journal of Rheumatology, 10/20/09
Relevance Score: 89%
Cutaneous vasculitis induced by TNF inhibitors: a report of three cases
Modern Rheumatology, 10/16/09
Relevance Score: 88%
Analysis of T-cell receptor usage in myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis
Clinical and Experimental Nephrology, 10/09/09
Relevance Score: 88%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Hyponatraemia induced by low-dose intravenous pulse cyclophosphamide
Nephrology Dialysis Transplantation, 12/11/09
Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study
International Clinical Psychopharmacology, 12/11/09
Valsartan plus hydrochlorothiazide for first-line therapy in hypertension
Expert Review of Cardiovascular Therapy , 12/11/09
Today in Vascular Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis
Current Opinion in Nephrology and Hypertension, 12/10/09
Aldosterone and cardiovascular risk
Current Hypertension Reports, 12/10/09
Targeting bone morphogenetic protein signaling on renal and vascular diseases
Current Opinion in Nephrology and Hypertension, 12/10/09